Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

A New Platform For Trivalent Bispecific Antibodies Used For T-Cell Redirected Killing Of B-Cell Malignancies

Diane L Rossi, M.S., Edmund A Rossi, Ph.D, David M Goldenberg, ScD, MD, Chien-Hsing Chang, Ph.D

Blood (2013) 122 (21): 3078.

https://doi.org/10.1182/blood.V122.21.3078.3078

Published: 2013

Journal Articles

Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab

Edmund A. Rossi, David M. Goldenberg, Rosana Michel, Diane L. Rossi, Daniel J. Wallace, Chien-Hsing Chang

Blood (2013) 122 (17): 3020–3029.

https://doi.org/10.1182/blood-2012-12-473744

Published: 2013

Includes: Supplemental data

Journal Articles

A Novel T-Cell Redirecting Anti-CD19-F(ab) 2 /CD3scFv Bispecific Antibody Exhibits Potent Lymphoma Cytotoxicity.

Diane L Rossi, M.S., Edmund A Rossi, Ph.D, Thomas M Cardillo, Ph.D, David M Goldenberg, ScD, MD, Chien-Hsing Chang, Ph.D

Blood (2012) 120 (21): 2762.

https://doi.org/10.1182/blood.V120.21.2762.2762

Published: 2012

Journal Articles

Preclinical studies on targeted delivery of multiple IFNα2b to HLA-DR in diverse hematologic cancers

Edmund A. Rossi, Diane L. Rossi, Thomas M. Cardillo, Rhona Stein, David M. Goldenberg, Chien-Hsing Chang

Blood (2011) 118 (7): 1877–1884.

https://doi.org/10.1182/blood-2011-03-343145

Published: 2011

Includes: Supplemental data

Journal Articles

Factor XII gene alteration in Hageman trait detected by TaqI restriction enzyme

F Bernardi, G Marchetti, P Patracchini, L del Senno, M Tripodi, A Fantoni, S Bartolai, F Vannini, L Felloni, L Rossi

Blood (1987) 69 (5): 1421–1424.

https://doi.org/10.1182/blood.V69.5.1421.1421

Published: 1987

Journal Articles

A method for simultaneous study of the karyotype, morphology, and immunologic phenotype of mitotic cells in hematologic malignancies

L Teerenhovi, S Knuutila, M Ekblom, L Rossi, GH Borgstrom, JK Tallman, L Andersson, A de la Chapelle

Blood (1984) 64 (5): 1116–1122.

https://doi.org/10.1182/blood.V64.5.1116.1116

Published: 1984

NARROW

A New Platform For Trivalent Bispecific Antibodies Used For T-Cell Redirected Killing Of B-Cell Malignancies

Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab

A Novel T-Cell Redirecting Anti-CD19-F(ab) 2 /CD3scFv Bispecific Antibody Exhibits Potent Lymphoma Cytotoxicity.

Preclinical studies on targeted delivery of multiple IFNα2b to HLA-DR in diverse hematologic cancers

Factor XII gene alteration in Hageman trait detected by TaqI restriction enzyme

A method for simultaneous study of the karyotype, morphology, and immunologic phenotype of mitotic cells in hematologic malignancies

Email alerts

ASH Publications

American Society of Hematology

A New Platform For Trivalent Bispecific Antibodies Used For T-Cell Redirected Killing Of B-Cell Malignancies

Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab

A Novel T-Cell Redirecting Anti-CD19-F(ab) 2 /CD3scFv Bispecific Antibody Exhibits Potent Lymphoma Cytotoxicity.

Preclinical studies on targeted delivery of multiple IFNα2b to HLA-DR in diverse hematologic cancers

Factor XII gene alteration in Hageman trait detected by TaqI restriction enzyme

A method for simultaneous study of the karyotype, morphology, and immunologic phenotype of mitotic cells in hematologic malignancies

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only